tiprankstipranks
pc:cyted

Cyted Health

Cyted Health is a leading gastrointestinal molecular diagnostics company focused on the early detection and prevention of esophageal adenocarcinoma through innovative, minimally invasive diagnostics. Founded by experts at the University of Cambridge, the company has developed the EndoSign® platform, an FDA-cleared device for minimally invasive esophageal cell collection, paired with advanced biomarker testing. Cyted Health's technology has been widely adopted by the UK's National Health Service, completing over 35,000 tests, and is expanding its presence in the U.S. to enhance patient care and broaden its advanced diagnostics portfolio.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$44M
Total Amount Raised$44M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$44M
Latest Funding Amount$44M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 02, 2025
Series B
$44.00M

Investors

Investor Name
Funding Round

Related News and Analysis